Abstract:The gross morphological appearance of ovine placentomes is known to alter in response to adverse intrauterine conditions that increase fetal cortisol exposure. The direct effects of fetal cortisol on the placentome morphology, however, remain unknown, nor is the functional significance of the different placentome types clear. The present study investigated the gross morphology of ovine placentomes in relation to placental nutrient delivery to sheep fetuses during late gestation and after experimental manipulat… Show more
“…There was a significant decrease in the number of type A, B, C, and D placentomes in the PR compared with the control fetuses. Despite the overall reduction in placentome number, there was no change in the proportion of placentomes that were type A, B, C, or D. This is interesting because it has previously been shown that the normal prepartum surge in cortisol, as well as earlier intrafetal cortisol infusion, increased the proportion of type A placentomes and decreased the proportion of type D placentomes in fetuses in late gestation (89). The lack of change in the proportion of type A and B placentomes in the PR fetuses may be due to the fact that there was no significant difference in plasma cortisol concentrations in this cohort.…”
Section: Discussionmentioning
confidence: 55%
“…The fetal organs were removed, and weights were recorded. Placentomes were removed from the uterus, and total placentome number, type (A-D), and weight were recorded (82,89). Placentome types were differentiated, as they are known to differ in vascularity and, therefore, may have a varying amount of blood flow (84).…”
Section: Fetal Cohort 1 Determination Of Distribution Of Cardiac Outputmentioning
Poudel R, McMillen IC, Dunn SL, Zhang S, Morrison JL. Impact of chronic hypoxemia on blood flow to the brain, heart, and adrenal gland in the late-gestation IUGR sheep fetus.
“…There was a significant decrease in the number of type A, B, C, and D placentomes in the PR compared with the control fetuses. Despite the overall reduction in placentome number, there was no change in the proportion of placentomes that were type A, B, C, or D. This is interesting because it has previously been shown that the normal prepartum surge in cortisol, as well as earlier intrafetal cortisol infusion, increased the proportion of type A placentomes and decreased the proportion of type D placentomes in fetuses in late gestation (89). The lack of change in the proportion of type A and B placentomes in the PR fetuses may be due to the fact that there was no significant difference in plasma cortisol concentrations in this cohort.…”
Section: Discussionmentioning
confidence: 55%
“…The fetal organs were removed, and weights were recorded. Placentomes were removed from the uterus, and total placentome number, type (A-D), and weight were recorded (82,89). Placentome types were differentiated, as they are known to differ in vascularity and, therefore, may have a varying amount of blood flow (84).…”
Section: Fetal Cohort 1 Determination Of Distribution Of Cardiac Outputmentioning
Poudel R, McMillen IC, Dunn SL, Zhang S, Morrison JL. Impact of chronic hypoxemia on blood flow to the brain, heart, and adrenal gland in the late-gestation IUGR sheep fetus.
“…142-145 d gestation. We have previously shown that sham-operated and unoperated fetal sheep are comparable (7). Finally, a further five unoperated animals were delivered preterm (127 d gestational age) and were compared with unoperated animals delivered at term to assess changes with advancing gestational age.…”
“…Together, these observations indicate that placental growth retardation may be the primary cause of the IUGR induced by synthetic glucocorticoids. On the other hand, manipulation of natural glucocorticoid levels within the physiological range in fetal sheep appears to have little effect on placental weight, although there are alterations in placental morphology [32,37]. This may have consequences for nutrient transfer as placental efficiency, measured as grams fetus produced per gram placenta, is increased after maternal glucocorticoid treatment in sheep, rats and non-human primates, despite the reduction in placental mass [38].…”
Hormones are both growth stimulatory and growth inhibitory in utero. They regulate tissue growth and development by controlling the rates of cell proliferation, apoptosis and differentiation in many fetal tissues. They also signal the level of resources available for intrauterine growth to the fe- tal tissues and relay back to the placenta the degree of mismatch between the actual fetal nutrient supply and the fetal nutrient demands for growth. They affect intrauterine growth by anabolic and catabolic actions on fetal metabolism and by altering the nutrient transfer capacity and endocrine function of the placenta. By modifying the fetal growth trajectory, hormones have a central role in programming development in utero and in determining the phenotypic outcome of changes in feto-placental growth during adverse intrauterine conditions. This review examines the role of hormones in feto-placental growth with particular emphasis on insulin, the insulin-like growth factors and glucocorticoids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.